发明名称 |
Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis |
摘要 |
A method for treating renal failure associated with advanced stage renal disease includes administering a soluble cytokine receptor to one or more of tumor necrosis factor alpha, interferon gamma or interleukin 6; or antibodies to one or more of interleukin 6 or interleukin 1 beta. The method can be used as a supplement to or as partial or complete replacement for dialysis. A pharmaceutical composition includes antibody or functional equivalent thereof to urea, creatinine, or both; antibody, functional equivalent or soluble cytokine receptor to tumor necrosis factor alpha, interferon gamma, interleukin 6, interleukin 1 beta or any combination thereof. The composition can be included in a kit. |
申请公布号 |
US8784822(B2) |
申请公布日期 |
2014.07.22 |
申请号 |
US200912367643 |
申请日期 |
2009.02.09 |
申请人 |
|
发明人 |
Skurkovich Boris;Millstein Ellen;Skurkovich Simon |
分类号 |
A61K39/395;A61K38/00 |
主分类号 |
A61K39/395 |
代理机构 |
Houston & Associates, LLP |
代理人 |
Houston & Associates, LLP |
主权项 |
1. A method for treating a patient suffering from chronic renal failure, associated with elevated levels of one or more of tumor necrosis factor alpha, interferon gamma or interleukin 6, the method comprising administering to the patient a soluble cytokine receptor to the one or more of tumor necrosis factor alpha, interferon gamma or interleukin 6, wherein the soluble cytokine receptor is administered in an amount effective to reduce levels of the one or more of tumor necrosis factor alpha, interferon gamma or interleukin 6. |
地址 |
|